IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice

The development of an effective therapy for Alzheimer’s disease (AD) is a major challenge to biomedical sciences. Because much of early AD pathophysiology includes hippocampal abnormalities, a viable treatment strategy might be to use trophic factors that support hippocampal integrity and function....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mellott, Tiffany J., Pender, Sarah M., Burke, Rebecca M., Langley, Erika A., Blusztajn, Jan Krzysztof
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986048/
https://ncbi.nlm.nih.gov/pubmed/24732467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0094287
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak